{"SPADE_N_14435": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14435", "Peptide Name": "FK-13 Q22A analog (Synthetic AMPs, UCLL1c)", "Source": "amino acid substitution, human cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FKRIVARIKDFLR", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1662.03, "PI": 11.72, "Hydrophobicity": -0.03, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Engelberg Y, Landau M. 2020", "Reference": "Nat Commun. 2020 Aug 4;11(1):3894. doi: 10.1038/s41467-020-17736-x.PubMed", "Title": "The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure."}], "Frequent Amino Acids": "RFI", "Absent Amino Acids": "CEGHMNOPQSTUWY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 7, "Polar Residues": 7, "Positive Residues": 5, "Negative Residues": 1, "Net Charge": 4, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) toFK-13R: 31%.Activity: active against M. luteus (MIC 33 uM) relative to the WT with an MIC of 22 uM and S. hominis (MIC 50 uM). Warning: other bacteria not tested.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_04256", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIV"}, {"SPADE_ID": "SPADE_N_04257", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRI"}, {"SPADE_ID": "SPADE_N_04258", "Similarity": 1.0, "Sequence": "EFKRIV"}]}}}